Truth Or D.A.R.E., Offering Opposing Lessons About Cannabis

By Noah Tomares, Research Analyst, New Frontier Data

Q: I see where the Drug Policy Alliance is rolling out its new Safety First: Real Drug Education for Teens curriculum for teachers and students; is that fact-based learning, or simply some reheated "Just Say No"-style opposition advertising?

A: In 2016, the Drug Abuse Resistance Education program, (D.A.R.E), removed cannabis from its list of gateway drugs. That it took the nonprofit, police-led organization 33 years after its inception to do so might not come as a surprise to the millions of former schoolchildren who sat through the standard 45-minute lectures presented nationwide between 1983 and 2009, though the program has been rethinking some of its approaches over the past decade.

A 1994 national study by the Department of Justice showed only small, short-term reductions in D.A.R.E. participants' use of tobacco — but not for alcohol or marijuana. While D.A.R.E. has more recently attempted to revise its curriculum, it remains fundamentally abstinence-based, perhaps hampered by its having been shaped less by prevention specialists than by police officers and schoolteachers.

Thus — despite recent reports cited by the Centers for Disease Control and Prevention (CDC) and the National Institute on Drug Abuse, among others, which show no corresponding increases in marijuana use by youths regardless of adult-use legalization in states including Colorado, Oregon, and Washington — D.A.R.E.'s website yet purports without sourcing that research is "still inconclusive regarding whether or not marijuana is a gateway drug and, if so, what other variables may contribute to an individual who has repeatedly used marijuana being drawn to experiment or use other types of illicit drugs." It goes on to claim that a student's use of marijuana is a high-risk behavior with unhealthy consequences, including unsourced allusions to heroin use.

Flash forward to today, and Safety First — a new set of 15 lessons created by the Drug Policy Alliance — challenges that approach. Focusing more on harm reduction than rote didacticism, Safety First introduces a conversation grounded in science and practical reality. While the success of the approach will not be evaluated for some time, ample data exists to compare and review the respective assumptions.

Despite D.A.R.E.'s contrary assertions, Monitoring the Future has published statistics on cannabis use among 8th, 10th, and 12th graders: Since peaking in the mid ‘90s, cannabis use among students has generally declined. Though the trend generally coincides with California's first legalizing medical cannabis, any diminished perception of harm or increased availability to the drug do not appear to have resulted in increased consumption among students.

Issues of behavior and consequences remain less clear: New Frontier Data's collected consumer data has found that consuming cannabis at a young age correlated with different behavioral differences in adults. The most noticeable behavioral differences are exhibited by those individuals who first consume cannabis when younger than 14 years old (about 6% of total consumers).

Individuals who consume cannabis before the age of 14 are more likely to consume cannabis daily later in life. They are more likely than older users to self-identify as medical consumers, and to have a broader range of reasons for their consumption. They are also likelier to spend more money each month for cannabis products.

Another substantial shift occurs after consumers turn age 21. Individuals who first consume cannabis before age 21 are likelier to prefer cannabis to alcohol. Conversely, those who reach legal drinking age before consuming cannabis are likelier to prefer alcohol; such older individuals are also more likely to consider their cannabis consumption private, and to consume in isolation.

As detailed in New Frontier Data's 2018-2019 Cannabis Consumer Report: Archetypes, Preferences & Trends based on a groundbreaking survey of more than 3,000 U.S. cannabis consumers about their attitudes, perceptions and usage behavior, they consistently did not consider cannabis to be a gateway drug: 72% of all those surveyed disagreed with the statement "using cannabis has made me more likely to try illicit drugs."

Whether such differentiations define "high-risk behavior and unhealthy consequences" remains uncertain. What is clear is that there are measurable differences based on an individual's age of first use. For more detailed examination, please return to the CannaBit for New Frontier Data's forthcoming "Age of First Use" infographic.

The post Ask Our Experts 10/20/19: Truth or D.A.R.E., Offering Opposing Lessons About Cannabis appeared first on New Frontier Data.

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Image Sourced from PIxabay

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsMarketsGeneralcannabis industryNew Frontier Data
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...